Latest News
Labcorp receives FDA approval for melanoma companion diagnostic
10 August 2026 - Labcorp (NYSE: LH), a provider of comprehensive laboratory services, disclosed on Monday that it has received U.S. Food and Drug Administration approval for its PGDx elio tissue complete CDx as a companion diagnostic to identify pati...
AbCellera reports positive Phase 2 results for menopause treatment ABCL635
10 August 2026 - Biotechnology company AbCellera (Nasdaq: ABCL) on Monday reported positive topline Phase 2 results for ABCL635, an investigational neurokinin 3 receptor antagonist antibody being developed as a non-hormonal, long-acting treatment for...
Bristol Myers Squibb to invest USD2.3bn in Houston manufacturing campus
10 August 2026 - Biopharmaceutical company Bristol Myers Squibb (BMS) (NYSE:BMY) announced on Monday that it has selected Houston, Texas, for a new multi-modal manufacturing campus representing an investment of approximately USD2.3bn aimed at acceler...
BeOne Medicines and Revolution Medicines expand oncology collaboration
10 August 2026 - BeOne Medicines Ltd (Nasdaq: ONC) (HKEX: 06160;) (SSE: 688235) and Revolution Medicines Inc (Nasdaq: RVMD) announced on Monday that the two oncology companies have entered a multi-part collaboration to develop combinations of selecte...
Almirall partners with CrystalO to develop small molecules for medical dermatology
10 August 2026 - Spanish pharmaceutical company Almirall S.A. (BME:ALM) said on Monday that it has entered into a collaboration and licensing agreement with Shenzhen CrystalO Biopharma Technology Co Ltd to discover and develop novel small molecules f...